A simple, selective, rapid, precise and economical reverse phase HPLC method has been developed for the determination of satranidazole in pharmaceutical formulations. The method was carried out on a isocratic ODS - C18 (250 x 4.6mm i.d.,5 μ) column with a mobile phase consisting of Acetonitrile , 0.025M Ammonium phosphate buffer and 1.0% Ortho phosphoric acid in the ratio 65:35:5 v/v/v) at a flow rate 1.2mL/min. Detection was carried out at 318nm using UV lamp visible detector. The developed method was validated in terms of accuracy, precision, linearity, limit of detection, limit of quantitation and solution stability. The proposed method can be used for the estimation of satranidazole in pharmaceutical formulations.
Comments: 5 Pages. OK
[v1] 2019-05-19 06:08:24
Unique-IP document downloads: 1 times
Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.
Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.